Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03822195

Lectine Pathway in Unstable Carotid Plaque

Evaluation of Lectine Pathway in Assessment of Unstable Carotid Plaque

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The study is aimed to investigate the possible role of lectin pathway - an alternative pathway of complement activation - in affecting stability of carotid atherosclerotic plaques and the possible correlations with clinical neurologic features.

Detailed description

In addition to the known hemodynamic criteria, instable carotid plaques can be responsible for brain ischemia, therefore is paramount to identify preoperatively possible markers of plaque instability. The study is aimed to investigate the possible role of lectin pathway - an alternative pathway of complement activation - in affecting stability of carotid atherosclerotic plaques and the possible correlations with clinical neurologic features. Study population will include 40 patients with internal carotid artery stenosis \>=70% (assessed by echocolordoppler), symptomatic or asymptomatic, surgically treated by endoarterectomy. Removed plaques will be evaluated by histologic exam and immunofluorescence for ficolins 1-2-3 and Mannose Binding Lectin (MBL). Plasma samples will be used for ELISA test of lectin pathway complement activation.

Conditions

Interventions

TypeNameDescription
PROCEDURECarotid endoarterectomySurgical removal of carotid bifurcation plaque and arterial repair (direct suture or patch)

Timeline

Start date
2019-04-01
Primary completion
2021-01-31
Completion
2021-02-28
First posted
2019-01-30
Last updated
2020-07-24

Source: ClinicalTrials.gov record NCT03822195. Inclusion in this directory is not an endorsement.